Amgen
The Postdoctoral Fellow - Biocatalysis will develop and optimize manufacturing routes for small molecule and hybrid drugs by creating AI/ML-based tools for biocatalyst discovery and engineering. This two‑year fellowship focuses on protein design, enzyme discovery from metagenomic databases, and active learning through enzyme evolution campaigns, with a start date in Q4 2026 or Q1 2027.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
18% above the average for this role
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Scientist, Biocatalysis & Protein Engineering
alnylam
Biocatalysis and Protein Engineering - Industrial Post Doctoral Researcher in Global Discovery Chemistry (Novartis Genesis Labs)
Novartis
Postdoctoral Fellow
Indiana University
Postdoctoral Fellow
Indiana University
Postdoctoral Fellow
PeopleAdmin
Postdoctoral Fellow
Indiana University